Jingkun Qu

机构：Second Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0002-5064-2832

发表论文 87 篇 · 总被引 1804 次 · h-index 23

代表论文

• High dose Vitamin C inhibits PD-L1 by ROS-pSTAT3 signal pathway and enhances T cell function in TNBC (2023 · International Immunopharmacology · 被引 31)
• Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes (2023 · Cancer Science · 被引 21)
• Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment (2023 · Molecular Pharmaceutics · 被引 18)
• Recent Advances in Smart Linkage Strategies for Developing Drug Conjugates for Targeted Delivery (2025 · Topics in Current Chemistry · 被引 12)
• CD39 inhibitor (POM-1) enhances radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells by promoting apoptosis through the Bax/Bcl-2/Caspase 9/Caspase 3 pathway (2024 · International Immunopharmacology · 被引 9)
• Deep neural network provides personalized treatment recommendations for de novo metastatic breast cancer patients (2024 · Journal of Cancer · 被引 7)